Body Image, Identity Development, and Social Media Use Among Youth With Visual Impairment: A Single Case Intervention Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-18
SponsorUniversitaire Ziekenhuizen KU Leuven

About this trial

1\. Introduction

This 3-week single case intervention study is funded by the Horizon Europe Research Program and is part of the VIPPSTAR project (Project 101156763 - VIPPSTAR "Visually Impaired children and adolescents: bridging the gap with Personalized Prevention Strategies, Tools, Approaches, and Resources). Within this project, the Belgian consortium will focus on the development of body image in relation to the social media use of children (10-11 years old) and adolescents (12-18 years old) with visual impairment (VI). This intervention study builds upon the insights done in earlier studies within the project, a focus group study and daily diary study. In the intervention study, children and adolescents with visual impairment will complete digital body image exercises through the first version of VIPPSTAR app. It is important to note that the data collection for this particular study will be limited to Flanders, Belgium, and will not extend to the other countries involved in the VIPPSTAR project. Furthermore, the ethical approval obtained for this study is specifically for collecting data from Flemish participants only, ensuring compliance with local ethical guidelines and regulations.

Eligibility criteria

Qualifiers

Children with (C)VI

Participants should be aged between 10-18 years old

Participants should be able to understand Dutch sufficiently

Participants should be cognitively able to comprehend the questions

Disqualifiers

Intellectual disability of such severity that they are unable to respond to the questions (as indicated by parents)

Non-Dutch Speaking (as indicated by parents)

Trial design

Treatments tested in this trial

  • Body image intervention

Treatment groups

15 Participants
are divided into 1 treatment group

Sponsors and collaborators